As of 4:00pm ET
| -0.49 / -1.25%|
The 10 analysts offering 12-month price forecasts for Medicines Co have a median target of 57.00, with a high estimate of 80.00 and a low estimate of 44.00. The median estimate represents a +47.17% increase from the last price of 38.73.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.